Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Xu, Fang ^a   Yao, Ping Ping ^a   Xia, Yong ^a   Qian, Lei ^a   Yang, Zhang Nv ^a   Xie, Rong Hui ^a   Sun, Yi Sheng ^a   Lu, Hang Jing ^a   Miao, Zi Ping ^a   Li, Chan ^a   Li, Xiao ^b   Liang, Wei Feng ^c   Huang, Xiao Xiao ^d   Xia, Shi Chang ^a   Chen, Zhi Ping ^a   Jiang, Jian Min ^a   Zhang, Yan Jun ^a   Mei, Ling Ling ^a   Liu, She Lan ^a   Gu, Hua ^a   Xu, Zhi Yao ^e   Fu, Xiao Fei ^f   Zhu, Zhi Yong ^a   Zhu, Han Ping ^a   more..

^a ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d Hangzhou Sixth People's Hospital   (China)

^e WENZHOU MEDICAL UNIVERSITY   (China)

^f Jiaxing Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; ANTISERUM;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; HIND LIMB PARALYSIS; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOTHERAPY; INFECTION SENSITIVITY; INFLAMMATORY CELL; INTERSTITIAL PNEUMONIA; LUNG CONGESTION; LUNG EDEMA; LUNG HEMORRHAGE; LUNG LESION; MERIONES UNGUICULATUS; MORTALITY; NONHUMAN; PARALYSIS; PASSIVE IMMUNIZATION; PASSIVE TRANSPORT; PATHOGENESIS; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; VIRAL PHENOMENA AND FUNCTIONS; VIRAL TITER; VIRUS REPLICATION; ANIMAL; CHILD; DISEASE MODEL; ENTEROVIRUS A; GERBIL; HUMAN; IMMUNOLOGY; LUNG; LUNG DISEASE; NEUROLOGIC DISEASE; PROCEDURES; VIROLOGY;

ANIMALIA; GERBILLINAE; HUMAN ENTEROVIRUS 71; MERIONES UNGUICULATUS; MUS MUSCULUS;

ANIMALS; CHILD; DISEASE MODELS, ANIMAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; GERBILLINAE; HUMANS; IMMUNE SERA; IMMUNIZATION, PASSIVE; LUNG; LUNG DISEASES; NERVOUS SYSTEM DISEASES;

EID: 84929493261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119173     Document Type: Article

References (42)

1. Huang SW, Hsu YW, Smith DJ, Kiang D, Tsai HP, Lin KH, et al. Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol. 2009; 47: 3653-3662. doi: 10.1128/JCM.00630-09 PMID: 19776232
2. Chang LY, Huang YC, Lin TY. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet. 1998; 352: 367-368. PMID: 9717926
3. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999; 354: 1682-1686. PMID: 10568570
4. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999; 341: 929-935. PMID: 10498487
5. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999; 341: 936-942. PMID: 10498488
6. Zhang D, Lu J. Enterovirus 71 vaccine: close but still far. Int J Infect Dis. 2010; 14: e739-743. doi: 10.1016/j.ijid.2009.12.002 PMID: 20400350
7. Zeng M, El Khatib NF, Tu S, Ren P, Xu S, Zhu Q, et al. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol. 2012; 53: 285-289. doi: 10.1016/j.jcv.2011.12.025 PMID: 22265829
8. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014; 14: 308-318. doi: 10.1016/S1473-3099(13)70342-6 PMID: 24485991
9. Yang F, Du J, Hu Y, Wang X, Xue Y, Dong J, et al. Enterovirus coinfection during an outbreak of hand, foot, and mouth disease in Shandong, China. Clin Infect Dis. 2011; 53: 400-401. doi: 10.1093/cid/cir346 PMID: 21785005
10. Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol. 2009; 47: 2351-2352. doi: 10.1128/JCM.00563-09 PMID: 19439545
11. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009; 44: 262-267. doi: 10.1016/j.jcv.2009.02.002 PMID: 19269888
12. Jee YM, Cheon DS, Kim K, Cho JH, Chung YS, Lee J, et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol. 2003; 148: 1735-1746. PMID: 14505086
13. Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, et al. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 2002; 46: 621-627. PMID: 12437029
14. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003; 9: 78-85. PMID: 12533285
15. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000; 31: 678-683. PMID: 11017815
16. Tu PV, Thao NT, Perera D, Huu TK, Tien NT, Thuong TC, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007; 13: 1733-1741. doi: 10.3201/eid1311.070632 PMID: 18217559
17. Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 2012; 9: 8. doi: 10.1186/1743-422X-9-8 PMID: 22230340
18. Arita M, Ami Y, Wakita T, Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol. 2008; 82: 1787-1797. PMID: 18057246
19. Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A. 2013; 110: 14753-14758. doi: 10.1073/pnas.1217563110 PMID: 23959904
20. Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012; 86: 2121-2131. doi: 10.1128/JVI.06103-11 PMID: 22130542
21. Chen CS, Yao YC, Lin SC, Lee YP, Wang YF, Wang JR, et al. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol. 2007; 81: 8996-9003. PMID: 17567704
22. Ong KC, Badmanathan M, Devi S, Leong KL, Cardosa MJ, Wong KT. Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol. 2008; 67: 532-542. doi: 10.1097/NEN.0b013e31817713e7 PMID: 18520772
23. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009; 15: 794-797. doi: 10.1038/nm.1961 PMID: 19543284
24. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009; 15: 798-801. doi: 10.1038/nm.1992 PMID: 19543282
25. Liu J, Dong W, Quan X, Ma C, Qin C, Zhang L. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol. 2012; 157: 539-543. doi: 10.1007/s00705-011-1198-2 PMID: 22187102
26. Yao PP, Qian L, Xia Y, Xu F, Yang ZN, Xie RH, et al. Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model. PLoS One. 2012; 7: e51996. doi: 10.1371/journal.pone.0051996 PMID: 23284845
27. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. AmJHyg. 1938; 27:493-497.
28. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004; 78: 7916-7924. PMID: 15254164
29. Xiu JH, Zhu H, Xu YF, Liu JN, Xia XZ, Zhang LF. Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection. Virol J. 2013; 10: 215. doi: 10.1186/1743-422X-10-215 PMID: 23809248
30. Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One. 2013; 8: e57591. doi: 10.1371/journal.pone.0057591 PMID: 23451246
31. Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol. 2004; 85: 2981-2989. PMID: 15448361
32. Wang YF, Yu CK. Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci. 2014; 21: 31. doi: 10.1186/1423-0127-21-31 PMID: 24742252
33. Wu JM, Wang JN, Tsai YC, Liu CC, Huang CC, Chen YJ, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002; 109: E26-. PMID: 11826236
34. Ho M. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect. 2000; 33: 205-216. PMID: 11269363
35. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998; 133: 795-798. PMID: 9842048
36. Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol. 2000; 17: 13-22. PMID: 10814934
37. Kao SJ, Yang FL, Hsu YH, Chen HI. Mechanism of fulminant pulmonary edema caused by enterovirus 71. Clin Infect Dis. 2004; 38: 1784-1788. PMID: 15227628
38. Manki A, Oda M, Seino Y. Neurologic diseases of enterovirus infections: polioviruses, coxsackieviruses, echoviruses, and enteroviruses type 68-72. Nihon Rinsho. 1997; 55: 849-854. PMID: 9434576
39. Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002; 109: e88. PMID: 12042582
40. Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004; 291: 222-227. PMID: 14722149
41. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, et al. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci. 2000; 7: 523-528. PMID: 11060501
42. Pallansch M, Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, eds. Fields'Virology. 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins;. 2007: pp840-894.